About this trial
Mental health disorders pose a significant burden on adolescent populations globally, often accompanied by sleep disturbances. Emerging evidence suggests that addressing sleep issues can improve mental health outcomes, while physical activity is increasingly recognized as beneficial for both sleep and mental well-being. This study aims to assess the effectiveness of a novel intervention (SLEEPAC), combining cognitive-behavioral therapy for insomnia (CBT-I), circadian treatment, and PA counseling, compared to treatment as usual (TAU), in improving psychopathology among adolescent psychiatric outpatients with sleep disturbances. Secondary outcomes include improvements in sleep health, physical activity levels, cognitive performance and self-esteem. Additionally, the study seeks to explore the predictive value of sleep neurophysiological biomarkers using high-density sleep electroencephalography (EEG), contributing to advancements in precision psychiatry for this population.
Eligibility criteria
Qualifiers
Aged between 13 to 18 years
Presence of insomnia and/or delayed sleep-wake phase disorder
At least one further diagnosis of DSM-5
Written informed consent of parents / primary caregiver
Disqualifiers
Organic sleep- and brain disorders (i.e., obstructive sleep apnea, narcolepsy, epilepsy)
Suffering from medical conditions, which prevent participation in physical activity
Changes to medication regime during the study protocol
Color-blindness (due to stroop test)
Trial design
Treatments tested in this trial
- SLEEPAC
Treatment groups
Sponsors and collaborators
Christin Lang
Lead sponsor
University of Basel
Sponsor institution
Department of Sport, Exercise, and Health, University of Basel
Collaborator
University Hospital of Child and Adolescent Psychiatry and Psychotherapy
Collaborator
University Children's Hospital Basel
Collaborator
Psychiatry Baselland
Collaborator